Humana Company Profile (NYSE:HUM)

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana declared a dividend on Thursday, August 17th. Stockholders of record on Friday, September 29th will be given a dividend of $0.40 per share on Monday, October 16th. The ex-dividend date of this dividend is Thursday, September 28th. View Humana's Dividend History.

Humana announced that its board has approved a share buyback plan on Tuesday, April 11th 2017, which authorizes the company to buyback $2,250,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 7.3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its stock is undervalued.

Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, August, 2nd. The company reported $3.49 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same quarter last year, the business earned $2.30 EPS. View Humana's Earnings History.

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for Humana.

Humana issued an update on its FY17 earnings guidance on Friday, September, 1st. The company provided earnings per share guidance of ~$11.50 for the period, compared to the Thomson Reuters consensus estimate of $11.51.

20 analysts have issued 1-year target prices for Humana's stock. Their predictions range from $200.00 to $300.00. On average, they anticipate Humana's share price to reach $253.11 in the next twelve months. View Analyst Ratings for Humana.

Here are some recent quotes from research analysts about Humana stock:

• 1. According to Zacks Investment Research, "Humana is well poised to grow on its strong government business. Its top-line has been witnessing an uptrend from past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remains a positive.  Following its strong second-quarter 2017 results, it raised its 2017 adjusted EPS guidance. The company has also seen the Zacks Consensus Estimate for the current year earnings being revised upward in last 30 days. Although the shares have performed in line with the industry in a year's time, its strong fundamentals are likely to help the stock in gaining momentum going forward. However, the company's individual commercial business has remained a drag over past few years. The company will release third quarter results on Nov 8, 2017." (10/17/2017)
• 2. Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)

Some companies that are related to Humana include Aetna (AET), Anthem (ANTM), Cigna Corporation (CI), Centene Corporation (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN), Triple-S Management Corporation (GTS), Catamaran Corp (CTRX), Catamaran Corp (SXCI) and Universal American (UAM).

Humana's management team includes the folowing people:

• Kurt J. Hilzinger, Independent Chairman of the Board
• Bruce D. Broussard, President, Chief Executive Officer, Director
• Brian A. Kane, Chief Financial Officer, Senior Vice President
• Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
• Brian P. LeClaire, Senior Vice President, Chief Information Officer
• Sam Deshpande, Senior Vice President, Chief Risk Officer
• Christopher M. Todoroff, Senior Vice President, General Counsel
• Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
• Jody L. Bilney, Senior Vice President, Chief Consumer Officer
• Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Humana's stock is owned by many different of retail and institutional investors. Top institutional investors include APG Asset Management N.V. (0.31%), PGGM Investments (0.12%), Robeco Institutional Asset Management B.V. (0.09%), Hermes Investment Management Ltd. (0.06%), Shell Asset Management Co. (0.05%) and State Treasurer State of Michigan (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Humana's stock was sold by a variety of institutional investors in the last quarter, including Quotient Investors LLC, State Treasurer State of Michigan, Quantitative Systematic Strategies LLC, Baker Ellis Asset Management LLC and Rockefeller Financial Services Inc.. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Humana's stock was acquired by a variety of institutional investors in the last quarter, including APG Asset Management N.V., PGGM Investments, Shell Asset Management Co., Hermes Investment Management Ltd., Robeco Institutional Asset Management B.V., Oakbrook Investments LLC, Mutual of America Capital Management LLC and Eqis Capital Management Inc.. View Insider Buying and Selling for Humana.

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Humana stock can currently be purchased for approximately $245.81.